0001104659-22-084767.txt : 20220801
0001104659-22-084767.hdr.sgml : 20220801
20220801170413
ACCESSION NUMBER: 0001104659-22-084767
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220728
FILED AS OF DATE: 20220801
DATE AS OF CHANGE: 20220801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Korbel Gregory Alan
CENTRAL INDEX KEY: 0001789032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 221125624
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
tm2222147-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-07-28
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001789032
Korbel Gregory Alan
535 BOYLSTON STREET
BOSTON
MA
02116
0
1
0
0
SVP, Chief Operating Officer
Common Stock
2022-07-28
4
A
0
24300
0
A
45762
D
Stock Option (right to Buy)
1.09
2022-07-28
4
A
0
35700
0
A
2032-07-28
Common Stock
35700
35700
D
These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock as follows: (i) 8,100 shares on July 28, 2023, (ii) 8,100 shares on July 28, 2024 and (iii) 8,100 shares on July 28, 2025, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
Twenty-five percent of these options vest on July 28, 2023, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
/s/ Scott M. Coiante, attorney-in-fact
2022-08-01